Join Dr. Rick Baehner, Chief Medical Officer of the Precision Oncology
division at Exact Sciences, in this episode of Becker's Healthcare Podcast. Dr.
Baehner discusses the evolving landscape of precision oncology and how Exact
Sciences is equipped to address the dynamic challenges and opportunities in
molecular testing for cancer patients. He shares key milestones that highlight the
company's commitment to innovation. Exploring the role of technology in cancer
prevention, early detection, and improved treatment guidance, Dr. Baehner explains
how Exact Sciences aligns with these objectives while addressing the concerns of
cancer leaders. Discover what exciting goals and developments are on the horizon
for Exact Sciences and tune in for Dr. Baehner's closing thoughts on this insightful
journey.
This episode is sponsored by Exact Sciences.
Cologuard is intended to screen adults 45 and older at average risk for colorectal
cancer. Rx only. Please see Cologuard Indications and Important Risk Information at
Cologuardhcp.com/risk-information. Exact Sciences' MCED and MRD tests are under
development. The features discussed in this podcast describe current development
goals. It has not been cleared or approved by the US Food and Drug Administration
or any other national regulatory authority.
POWERED BY BLUBRRY
